2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$47.52+$0.66 (+1.41%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.2BMarket Cap
- 141.05%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$47.52+$0.66 (+1.41%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.86 | ||
Change | +$0.06 (+0.13%) | ||
Open | $47.13 | ||
High | $47.28 | ||
Low | $45.60 | ||
Previous Close | $46.80 | ||
Volume | 755,580 | ||
30-Day Average Volume | 937,933 | ||
1-Week Change | -2.82% | ||
1-Month Change | 7.04% | ||
1-Year Change | 141.05% | ||
3-Year Change | 130.38% | ||
5-Year Change | 227.46% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $252.6M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $72.5M | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $173.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -266 | ||
Enterprise Value/Revenue | 32 | ||
P/B | -17 | ||
P/E | -167 | ||
PEG | -4 | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue